Theranos has a bizarre new plan to stop investors suing the discredited blood-testing company or its disgraced founder Elizabeth Holmes - by offering them extra shares.
The deal, reported by The Wall Street Journal citing people familiar with the matter, would see chief executive Elizabeth Holmes hand over a portion of her personal shares in the company, relinquishing majority ownership.
READ MORE: Billionaire to bust: Elizabeth Holmes' fall from grace
"This is an affirmative development for the company, providing a path forward in partnership with employees, investors and other stakeholders," Theranos director Daniel Warmenhoven told the Journal. "Elizabeth elected to contribute her own equity to protect any dilution of shares held by other parties."
Holmes raised more than half a billion dollars from investors hyping the company's non-existent "revolutionary" blood-testing technology, which she claimed could test for hundreds of diseases with a single drop of blood from the finger.